Jeffrey J Chalmers, PhD
College of Engineering
Chemical & Biomolecular Engineering
Cancer ● Coronary Disease ● Rupture ● Alzheimer Disease ● Carcinoma, Squamous Cell ● Breast Cancer
Jeffrey Chalmers, PhD, is a member of the Translational Therapeutics Program at the OSUCCC – James, where he brings a special perspective from the Chemical and Biomolecular Engineering Department in the College of Engineering.His research aids in the development of fundamental understanding and applications of the interaction of hydrodynamic and magnetic forces and cells. It ranges from the establishment of mathematical relationships detailing physical phenomena to the development of simple, robust instruments to use in a clinical setting. Results of one of his recent studies indicate that miR-21 and miR-29a are necessary for pro-tumor functions of myeloid cells, and that the CSF1-ETS2 pathway upstream of the miRs acts as a therapeutic target to inhibit M2 remodeling of macrophages during malignancy. Dr. Chalmers has co-authored numerous articles in well-respected publications such as Breast Cancer Research, Methods, Journal of Magnetism and Magnetic Materials and Frontiers in Oncology.